132 related articles for article (PubMed ID: 11509223)
1. Nefiracetam improves Morris water maze performance following traumatic brain injury in rats.
DeFord SM; Wilson MS; Gibson CJ; Baranova A; Hamm RJ
Pharmacol Biochem Behav; 2001; 69(3-4):611-6. PubMed ID: 11509223
[TBL] [Abstract][Full Text] [Related]
2. Delayed, post-injury treatment with aniracetam improves cognitive performance after traumatic brain injury in rats.
Baranova AI; Whiting MD; Hamm RJ
J Neurotrauma; 2006 Aug; 23(8):1233-40. PubMed ID: 16928181
[TBL] [Abstract][Full Text] [Related]
3. Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury.
Pike BR; Hamm RJ; Temple MD; Buck DL; Lyeth BG
J Neurotrauma; 1997 Dec; 14(12):897-905. PubMed ID: 9475371
[TBL] [Abstract][Full Text] [Related]
4. Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats.
Pike BR; Hamm RJ
Brain Res; 1995 Jul; 686(1):37-43. PubMed ID: 7583269
[TBL] [Abstract][Full Text] [Related]
5. Delayed glucose treatment improves cognitive function following fluid-percussion injury.
Kokiko-Cochran ON; Michaels MP; Hamm RJ
Neurosci Lett; 2008 May; 436(1):27-30. PubMed ID: 18355962
[TBL] [Abstract][Full Text] [Related]
6. Effects of nefiracetam on amnesia animal models with neuronal dysfunctions.
Hiramatsu M; Shiotani T; Kameyama T; Nabeshima T
Behav Brain Res; 1997 Feb; 83(1-2):107-15. PubMed ID: 9062668
[TBL] [Abstract][Full Text] [Related]
7. A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats.
Takeo S; Niimura M; Miyake-Takagi K; Nagakura A; Fukatsu T; Ando T; Takagi N; Tanonaka K; Hara J
Br J Pharmacol; 2003 Feb; 138(4):642-54. PubMed ID: 12598418
[TBL] [Abstract][Full Text] [Related]
8. The effect of postinjury kindled seizures on cognitive performance of traumatically brain-injured rats.
Hamm RJ; Pike BR; Temple MD; O'Dell DM; Lyeth BG
Exp Neurol; 1995 Dec; 136(2):143-8. PubMed ID: 7498404
[TBL] [Abstract][Full Text] [Related]
9. Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury.
Reid WM; Hamm RJ
J Neurotrauma; 2008 Mar; 25(3):248-56. PubMed ID: 18352838
[TBL] [Abstract][Full Text] [Related]
10. Effects of fluoxetine on the 5-HT1A receptor and recovery of cognitive function after traumatic brain injury in rats.
Wilson MS; Hamm RJ
Am J Phys Med Rehabil; 2002 May; 81(5):364-72. PubMed ID: 11964577
[TBL] [Abstract][Full Text] [Related]
11. Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury.
Zhu J; Hamm RJ; Reeves TM; Povlishock JT; Phillips LL
Exp Neurol; 2000 Nov; 166(1):136-52. PubMed ID: 11031090
[TBL] [Abstract][Full Text] [Related]
12. Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury.
Temple MD; Hamm RJ
Brain Res; 1996 Nov; 741(1-2):246-51. PubMed ID: 9001729
[TBL] [Abstract][Full Text] [Related]
13. Persistent effects of delayed treatment with nefiracetam on the water maze task in rats with sustained cerebral ischemia.
Takeo S; Fukatsu T; Miyake-Takagi K; Takagi N; Niimura M; Nagakura A; Ando T; Tanonaka K
J Pharmacol Exp Ther; 2003 Feb; 304(2):513-23. PubMed ID: 12538802
[TBL] [Abstract][Full Text] [Related]
14. Flumazenil administration attenuates cognitive impairment in immature rats after controlled cortical impact.
Ochalski PG; Fellows-Mayle W; Hsieh LB; Srinivas R; Okonkwo DO; Dixon CE; Adelson PD
J Neurotrauma; 2010 Mar; 27(3):647-51. PubMed ID: 19929186
[TBL] [Abstract][Full Text] [Related]
15. Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat.
Okiyama K; Smith DH; White WF; Richter K; McIntosh TK
J Neurotrauma; 1997 Apr; 14(4):211-22. PubMed ID: 9151770
[TBL] [Abstract][Full Text] [Related]
16. The nootropic compound BMY-21502 improves spatial learning ability in brain injured rats.
Pierce JE; Smith DH; Eison MS; McIntosh TK
Brain Res; 1993 Oct; 624(1-2):199-208. PubMed ID: 8252392
[TBL] [Abstract][Full Text] [Related]
17. Administration of MS-275 improves cognitive performance and reduces cell death following traumatic brain injury in rats.
Cao P; Liang Y; Gao X; Zhao MG; Liang GB
CNS Neurosci Ther; 2013 May; 19(5):337-45. PubMed ID: 23551690
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative modulation of the GABA(A) receptor and outcome after traumatic brain injury in rats.
O'Dell DM; Gibson CJ; Wilson MS; DeFord SM; Hamm RJ
Brain Res; 2000 Apr; 861(2):325-32. PubMed ID: 10760494
[TBL] [Abstract][Full Text] [Related]
19. Cognitive evaluation of traumatically brain-injured rats using serial testing in the Morris water maze.
Thompson HJ; LeBold DG; Marklund N; Morales DM; Hagner AP; McIntosh TK
Restor Neurol Neurosci; 2006; 24(2):109-14. PubMed ID: 16720946
[TBL] [Abstract][Full Text] [Related]
20. Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors.
Zhao X; Yeh JZ; Narahashi T
Ann N Y Acad Sci; 2001 Jun; 939():179-86. PubMed ID: 11462769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
